Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
Thesis (PhD)--Stellenbosch University, 2020.
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | en_ZA |
| Published: |
Stellenbosch : Stellenbosch University
2020
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
- Pharmacokinetic-Pharmacogenetic-and-Pharmacodynamic Adherence Relationships in Cohort South African HIV Infected Children on Lopinavir-and Nevirapine-Based Regimens
- Lopinavir/ Ritonavir, an Antiretroviral Drug, Lowers Sperm Quality and Induces Testicular Oxidative Damage in Rats
- Drug repurposing and optimisation to improve tuberculosis treatment
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis